基石药业 - 收益表 (TTM)

基石药业
US ˙ OTCPK ˙ KYG2588M1006

收益表 (TTM)

基石药业 损益表显示一段时间内收入和支出的变化。损益表数据包括销售和收入、毛利、研发、销售、一般和管理费用、经营收入、所得税费用、利息费用、营业外收入、每股收益和已发行股票。

除每股单位外,所有数字都是 1,000,000。

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
收入 519 1,039 1,079 1,118 681 244 335 426 454 481 481 481 472 464 460 457 432 407 305 202
改变 (%) 100.33 3.82 3.68 -39.10 -64.21 37.40 27.22 6.49 6.10 -0.03 -0.03 -1.79 -1.82 -0.79 -0.79 -5.40 -5.71 -25.14 -33.58
收入百分比 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
销售成本 121 241 257 273 190 107 138 168 186 203 211 218 189 160 147 134 150 167 197 227
改变 (%) 100.00 6.46 6.07 -30.41 -43.69 28.79 22.35 10.29 9.33 3.77 3.64 -13.46 -15.55 -8.12 -8.83 12.50 11.11 17.99 15.25
收入百分比 23.28 23.24 23.83 24.38 27.86 43.83 41.09 39.51 40.92 42.17 43.77 45.38 39.99 34.40 31.86 29.27 34.81 41.02 64.66 112.18
毛营业利润 398 797 822 846 491 137 197 258 268 278 271 263 284 304 314 323 282 240 108 -25
改变 (%) 100.44 3.02 2.94 -41.91 -72.14 44.13 30.62 4.01 3.86 -2.80 -2.88 7.90 7.32 3.05 2.96 -12.81 -14.69 -55.14 -122.89
收入百分比 76.72 76.76 76.17 75.62 72.14 56.17 58.91 60.49 59.08 57.83 56.23 54.62 60.01 65.60 68.14 70.73 65.19 58.98 35.34 -12.18
销售、一般及行政费用 424 485 534 583 622 661 658 655 616 576 546 516 449 382 326 271 241 212 196 181
改变 (%) 14.36 10.15 9.22 6.72 6.29 -0.49 -0.50 -5.99 -6.38 -5.25 -5.54 -12.97 -14.90 -14.55 -17.03 -10.94 -12.29 -7.15 -7.70
收入百分比 81.73 46.65 49.50 52.14 91.37 271.37 196.53 153.71 135.69 119.74 113.48 107.22 95.02 82.37 70.94 59.33 55.86 51.96 64.45 89.55
研发 1,480 1,405 1,389 1,373 1,339 1,305 1,182 1,059 836 614 574 534 518 501 468 407 252 124 143 163
改变 (%) -5.12 -1.12 -1.13 -2.49 -2.55 -9.43 -10.41 -21.00 -26.58 -6.50 -6.95 -3.08 -3.18 -6.75 -12.89 -38.03 -50.90 15.64 13.53
收入百分比 285.50 135.22 128.78 122.80 196.64 535.43 352.93 248.53 184.37 127.59 119.33 111.07 109.61 108.10 101.60 89.21 58.44 30.43 47.01 80.35
运营支出 2,025 2,131 2,180 2,229 2,151 2,073 1,978 1,882 1,638 1,394 1,331 1,268 1,156 1,043 941 812 644 503 537 571
改变 (%) 5.23 2.30 2.25 -3.50 -3.62 -4.61 -4.83 -12.98 -14.91 -4.49 -4.70 -8.89 -9.75 -9.82 -13.69 -20.67 -21.96 6.83 6.39
收入百分比 390.50 205.11 202.11 199.32 315.87 850.64 590.54 441.75 360.98 289.49 276.58 263.67 244.62 224.86 204.40 177.82 149.11 123.42 176.11 282.09
营业收入 -1,506 -1,092 -1,101 -1,111 -1,470 -1,829 -1,643 -1,456 -1,184 -912 -850 -787 -683 -579 -480 -355 -212 -95 -232 -369
改变 (%) -27.51 0.86 0.85 32.36 24.45 -10.21 -11.37 -18.68 -22.96 -6.84 -7.34 -13.22 -15.24 -17.05 -26.05 -40.30 -55.04 143.33 58.90
收入百分比 -290.50 -105.11 -102.11 -99.32 -215.87 -750.64 -490.54 -341.75 -260.98 -189.49 -176.58 -163.67 -144.62 -124.86 -104.40 -77.82 -49.11 -23.42 -76.11 -182.09
利息花费 -1 -1 -2 -3 -3 -2 -3 -3 -6 -8 -10 -11 -12 -12 -13 -14 -15 -15 -14 -14
改变 (%) 54.21 74.20 42.60 -15.81 -18.78 16.48 14.15 92.18 47.97 17.33 14.77 1.77 1.74 10.47 9.48 3.05 2.96 -4.75 -4.99
收入百分比 -0.17 -0.13 -0.21 -0.29 -0.41 -0.92 -0.78 -0.70 -1.26 -1.76 -2.07 -2.37 -2.46 -2.55 -2.84 -3.13 -3.41 -3.72 -4.74 -6.78
净利 -1,482 -1,221 -1,272 -1,324 -1,622 -1,920 -1,714 -1,508 -1,205 -903 -827 -750 -559 -367 -255 -142 -117 -91 -234 -377
改变 (%) -17.64 4.20 4.03 22.53 18.39 -10.74 -12.03 -20.07 -25.10 -8.44 -9.22 -25.53 -34.28 -30.62 -44.14 -17.95 -21.88 156.72 61.05
收入百分比 -285.88 -117.54 -117.96 -118.36 -238.16 -787.84 -511.82 -353.92 -265.65 -187.53 -171.75 -155.97 -118.27 -79.17 -55.36 -31.17 -27.04 -22.40 -76.81 -186.23

Source: Capital IQ

Other Listings
DE:PH4 €1.35
HK:2616 HK$12.90
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista